Pt-141 10mg

PT-141 10mg Research Vial

The Driada Medical PT-141 10mg Research Vial is manufactured to high purity standards and supplied exclusively for laboratory and scientific research applications.

Each vial contains 10mg of research-grade PT-141, produced under strict quality control to ensure consistency, purity, and reliability for qualified research professionals.

Product Specifications

Compound: PT-141

Strength: 10mg

Format: Lyophilised Powder

Purity: ≥99%

Storage: Store refrigerated at 2–8°C. Do not freeze.

Research Use Only

Package Contents
1 × PT-141 10mg Research Vial
1 × 1ml Bacteriostatic Water

Important Notice
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease.

Purchasers are responsible for ensuring compliance with all applicable laws and regulations in their jurisdiction.

ℹ️ℹ️ℹ️ℹ️

What is PT-141 (Bremelanotide)?

PT-141, also known as Bremelanotide, is a synthetic peptide that activates melanocortin receptors in the brain to increase sexual desire and arousal. Unlike medications that work by increasing blood flow, PT-141 acts on the central nervous system. It is approved in the United States as Vyleesi® for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women. It is not approved for enhancing sexual performance or for use in men.

How It Works

- Activates melanocortin receptors (primarily MC3 and MC4) in the brain.

- Increases sexual desire and arousal.

- Works independently of blood flow or hormone levels.

- Effects typically begin within a few hours after injection.

Benefits

- May increase sexual desire.

- Can improve sexual arousal in some individuals.

- May enhance sexual satisfaction in people with specific sexual desire disorders.

Bodybuilding & Wellness

- Not a muscle-building or fat-loss peptide.

- Does not increase strength, endurance, or athletic performance.

- Sometimes used off-label for its effects on libido and sexual function.

Side Effects

- Nausea.

- Flushing.

- Headache.

- Injection site reactions.

- Vomiting.

- Nasal congestion.

Potential Risks

- Temporary increases in blood pressure.

- Decreased heart rate after dosing.

- Skin darkening (hyperpigmentation), especially with repeated use.

- May slow stomach emptying, which can affect the absorption of some oral medications.

- Should not be used in people with uncontrolled high blood pressure or certain cardiovascular conditions.

How It Is Taken

- Administered by subcutaneous injection.

- Typically used as needed before anticipated sexual activity rather than on a daily schedule.

- Dosing should follow medical guidance.

Current Status

Bremelanotide (PT-141) is approved in the United States for a specific medical indication in certain premenopausal women. Other uses, including use in men or for general sexual enhancement, are considered off-label and have not been approved by major regulators.

Summary

PT-141 (Bremelanotide) is a peptide that works on the brain to increase sexual desire and arousal rather than improving blood flow. While it has an approved medical use for a specific form of low sexual desire in certain women, its use for sexual enhancement or in men remains off-label and should only be considered under appropriate medical supervision.

#pt141 #bremelanotide #driadamedical #peptides #research #researchuseonly #laboratoryresearch #pt